Lorcaserin: the Latest FDA-approved Obesity Drug

The FDA recently approved a new drug called lorcaserin (brand name Belviq) for the treatment of obesity.  Lorcaserin causes an average of 13 lbs (5.8 kg) of weight loss over a year, compared to 5 lbs (2.2 kg) for placebo (1), which is less than the other recently approved drug Qsymia (formerly Qnexa; topiramate/phentermine).Learning about obesity drugs is always a good opportunity to gain insight into the mechanisms that underlie the development...

Recycled Guru?! Marilyn Diamond

I'm kinda surprised the community didn't go a bit a buzz when Anthony Colpo included this in a recent reader mail roundup:  Reader Glen sent along a link to comments made on FaceBook by Marilyn Diamond.  Who you ask?  Well as AC reminds us:... she co-authored a runaway best-selling diet book in 1985 with her then husband Harvey titled Fit For Life. It was enthusiastically endorsed...